RDA Financial Network lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 3.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,967 shares of the medical equipment provider’s stock after selling 302 shares during the period. Intuitive Surgical accounts for approximately 1.2% of RDA Financial Network’s portfolio, making the stock its 14th biggest holding. RDA Financial Network’s holdings in Intuitive Surgical were worth $4,158,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. State Street Corp raised its holdings in Intuitive Surgical by 1.4% in the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after acquiring an additional 210,363 shares during the last quarter. FMR LLC boosted its holdings in shares of Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares during the last quarter. Geode Capital Management LLC grew its position in shares of Intuitive Surgical by 1.9% in the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock valued at $3,677,194,000 after purchasing an additional 143,440 shares during the period. Fisher Asset Management LLC grew its position in shares of Intuitive Surgical by 1.8% in the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock valued at $2,349,441,000 after purchasing an additional 86,208 shares during the period. Finally, Baillie Gifford & Co. increased its stake in Intuitive Surgical by 0.6% in the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after purchasing an additional 24,183 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.
Insiders Place Their Bets
In other news, CFO Jamie Samath sold 270 shares of the business’s stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. The trade was a 2.99 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Mark Brosius sold 2,128 shares of the company’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the completion of the transaction, the senior vice president now owns 273 shares of the company’s stock, valued at $140,595. This trade represents a 88.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 48,190 shares of company stock worth $25,012,927 in the last 90 days. 0.80% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
Get Our Latest Stock Analysis on Intuitive Surgical
Intuitive Surgical Price Performance
NASDAQ:ISRG opened at $584.08 on Friday. The business’s 50-day moving average is $538.34 and its two-hundred day moving average is $497.08. The firm has a market capitalization of $208.04 billion, a PE ratio of 93.90, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $355.17 and a 12 month high of $585.50.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Equities analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
- Five stocks we like better than Intuitive Surgical
- What is a Death Cross in Stocks?
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
- Health Care Stocks Explained: Why You Might Want to Invest
- Top Growth Picks: 3 Low-Cost Stocks That Could Double in Value
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Is Johnson & Johnson Stock Set to Reward Long-Term Holders?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.